Figure 6.

Plasma interleukin-8 levels in pancreatic ductal adenocarcinoma patients receiving chemoimmunotherapy. A: Plasma interleukin (IL)-8 levels in 7 patients during treatment; B: Comparison of plasma IL-8 levels prior to treatment between super-responders [overall survival (OS) ≥ 1 year] and nonsuper-responders (OS < 1 year); C: Comparison of plasma IL-8 levels in super-responders prior to treatment and post-vaccination; D: Comparison of plasma IL-8 levels after 5 vaccinations in nonsuper-responders and super-responders after 5, 10, 15, 20, and 25 vaccinations. The values are expressed as means ± SD. ^aP < 0.05.